KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $559.3 million.

  • Zimmer Biomet Holdings' Cost of Revenue rose 384.33% to $559.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year increase of 675.13%. This contributed to the annual value of $2.2 billion for FY2024, which is 515.4% up from last year.
  • As of Q3 2025, Zimmer Biomet Holdings' Cost of Revenue stood at $559.3 million, which was up 384.33% from $592.2 million recorded in Q2 2025.
  • Zimmer Biomet Holdings' Cost of Revenue's 5-year high stood at $592.2 million during Q2 2025, with a 5-year trough of $436.3 million in Q1 2021.
  • Its 5-year average for Cost of Revenue is $524.0 million, with a median of $520.3 million in 2022.
  • Examining YoY changes over the last 5 years, Zimmer Biomet Holdings' Cost of Revenue showed a top increase of 5627.73% in 2021 and a maximum decrease of 1369.86% in 2021.
  • Over the past 5 years, Zimmer Biomet Holdings' Cost of Revenue (Quarter) stood at $536.5 million in 2021, then dropped by 3.02% to $520.3 million in 2022, then rose by 3.56% to $538.8 million in 2023, then increased by 8.89% to $586.7 million in 2024, then dropped by 4.67% to $559.3 million in 2025.
  • Its Cost of Revenue stands at $559.3 million for Q3 2025, versus $592.2 million for Q2 2025 and $549.8 million for Q1 2025.